.png){kind=icon}
.png){kind=icon}
Return
Discovery of VU6066098: A Selective and CNS-Penetrant mGlu2 NAM with Robust Antidepressant-; Antipsychotic-; and Procognitive-like Activity in Rodents
.png){kind=icon}
OA
AI
J
R
S
D
A
I
S
H
A
C
G
G
C
DOI：10.1021/acschemneuro.6c00324.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Herein, we report the discovery and development of an optimized mGlu2 Negative Allosteric Modulator (NAM) in vivo tool compound, VU6066098, based on a novel, structurally distinct chemotype. VU6066098 is a potent, selective, and CNS-penetrant mGlu2 NAM with excellent rat PK (CLp = 23.9 mL/min/kg, t1/2 = 2.2 h, %F = 100, Kp = 1.28, Kp,uu = 0.25), making it ideal to explore the therapeutic potential of selective mGlu2 inhibition in preclinical rat models. In a rat forced swim test, VU6066098 displayed an oral minimum effective dose (MED) of 1 mg/kg and was equi-efficacious to ketamine. In amphetamine-induced hyperlocomotion, VU6066098 displayed an oral minimum effective dose (MED) of 30 mg/kg. While in the preclinical cognitive tasks of rat novel object recognition and acquisition of contextual fear conditioning, VU6066098 produced robust dose-dependent effects at oral minimum effective doses (MED) of 3 mg/kg and 0.3 mg/kg, respectively. In a blast-related traumatic brain injury (TBI) model, administration of VU6066098 at a dose of 10 mg/kg IP was effective acutely, and the effect on NOR memory was sustained up to 30 days postdose. Thus, mGlu2 NAMs show therapeutic potential for the treatment of a broad range of affective and cognitive symptoms associated with Major Depressive Disorder, Alzheimer’s disease, TBI, and acute psychosis; moreover, these data strongly support further optimization of mGlu2 NAMs for future clinical development.
Keywords:
Central nervous system
Nicotinamide
Peptides and proteins
Receptors
Rodent models
metabotropic glutamate receptor subtype 2 (mGlu2)
novel object recognition (NOR)
amphetamine-induced hyperlocomotion (AHL)
contextual fear conditioning (CFC)
blast-related traumatic brain injury (TBI)
forced swim
depression
negative allosteric modulator (NAM)
Journal
IF:
3.9
Papers:
4.5K
Citations:
1.3W
Organization
Cited Papers